Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Research Site 4, Redwood City, California Research Site 2, Chicago, Illinois Research Site 8, Iowa City, Iowa Research Site 6, Boston, Massachusetts Research Site 1, St Louis, Missouri